Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607)
China flag China · Delayed Price · Currency is CNY
20.91
-0.23 (-1.09%)
Nov 13, 2024, 3:00 PM CST

Shanghai Pharmaceuticals Holding Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
4,0253,7685,6175,0934,4964,081
Upgrade
Depreciation & Amortization
2,0282,0282,2222,1402,1381,885
Upgrade
Other Amortization
351.28351.28195.59186.89160.66134.85
Upgrade
Loss (Gain) From Sale of Assets
-92.48-92.48-1,439-58.29-52.15-71.34
Upgrade
Asset Writedown & Restructuring Costs
70.6570.65322.3988.98502.04801.09
Upgrade
Loss (Gain) From Sale of Investments
105.5105.530.06204.41-126.5-779.37
Upgrade
Provision & Write-off of Bad Debts
254.34254.34276.33-54.29-84.83159.29
Upgrade
Other Operating Activities
3,3133,0902,196860.271,8242,381
Upgrade
Change in Accounts Receivable
-6,432-6,432-10,081-6,156-4,072-5,084
Upgrade
Change in Inventory
-2,304-2,304-7,112-3,201932.663.14
Upgrade
Change in Accounts Payable
4,5864,58612,6455,7931,3602,667
Upgrade
Operating Cash Flow
5,7125,2324,7435,0616,8456,022
Upgrade
Operating Cash Flow Growth
-20.72%10.29%-6.28%-26.06%13.65%92.09%
Upgrade
Capital Expenditures
-2,521-2,971-2,685-4,119-3,010-2,753
Upgrade
Sale of Property, Plant & Equipment
191.2179.15160.34190.9383.86141.9
Upgrade
Cash Acquisitions
-294.02-357.08-84.33-1,15356.2-759.59
Upgrade
Divestitures
12.860.5106.8-1,454110.1365.9
Upgrade
Investment in Securities
2,959-436.23-10,486-86.68-808.25-2,522
Upgrade
Other Investing Activities
517.941,092514.75606.311,5621,243
Upgrade
Investing Cash Flow
865.66-2,492-12,473-6,016-1,706-4,584
Upgrade
Short-Term Debt Issued
-163.6363.0429.26174.66205.11
Upgrade
Long-Term Debt Issued
-79,19363,64456,54749,26540,047
Upgrade
Total Debt Issued
75,04779,35764,00856,57649,44040,252
Upgrade
Short-Term Debt Repaid
--1,325-394.85-329.58-267.97-355.14
Upgrade
Long-Term Debt Repaid
--73,120-60,557-53,003-48,306-38,966
Upgrade
Total Debt Repaid
-74,486-74,445-60,952-53,333-48,574-39,321
Upgrade
Net Debt Issued (Repaid)
560.594,9123,0553,243865.24930.67
Upgrade
Issuance of Common Stock
18.32106.4213,982---
Upgrade
Common Dividends Paid
-3,455-3,981-3,094-2,676-2,418-2,584
Upgrade
Other Financing Activities
449.12-805.36-1,805998.55291.92-672.31
Upgrade
Financing Cash Flow
-2,427231.8512,1391,566-1,261-2,326
Upgrade
Foreign Exchange Rate Adjustments
32.39-5.58-12.44-50.32-17.63-1.61
Upgrade
Net Cash Flow
4,1832,9664,396561.063,860-889.3
Upgrade
Free Cash Flow
3,1912,2612,058942.553,8353,269
Upgrade
Free Cash Flow Growth
-23.84%9.83%118.40%-75.42%17.30%174.25%
Upgrade
Free Cash Flow Margin
1.17%0.87%0.89%0.44%2.00%1.75%
Upgrade
Free Cash Flow Per Share
0.860.610.590.331.351.15
Upgrade
Cash Income Tax Paid
7,0597,3847,5996,2395,8495,622
Upgrade
Levered Free Cash Flow
898.58-1,521-595.85-1,3741,482664.12
Upgrade
Unlevered Free Cash Flow
2,030-343.35459.95-425.522,3651,542
Upgrade
Change in Net Working Capital
3,0925,1204,3973,3311,5102,178
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.